ONCOINVENT SOLUTIONS AS
Norwegian biotech transforming cancer care via direct alpha therapy.
Overview
- 45
- Employees
- Unknown
- Revenue
- 2025
- Founded
Description
Oncoinvent ASA is a Norwegian clinical-stage biotechnology company dedicated to transforming cancer care. Their core mission revolves around developing treatments utilizing direct alpha therapy technology. This approach employs highly potent alpha radiation from radionuclides, specifically designed...
Tags
Keywords
Company Information
- Industry
- Unknown
- Legal Form
- Aksjeselskap
- VAT Number
- Unknown
Decision Makers
No decision makers found yet
Similar Companies
20 similar companies in Funnelfeedr
NUCLITHERA AS
8 employeesDeveloping targeted alpha and beta emitters for metastatic cancer treatment.
BIO INVENTION AS
Clinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
ARTBIO AS
21 employeesDeveloping novel alpha radioligand therapies to redefine cancer care.
BioInvent International Aktiebolag
100–199 employeesClinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
MyCural Therapeutics AB
10–19 employeesDeveloping novel small molecule therapies targeting the MYC oncoprotein.
Browse More
ONCOINVENT SOLUTIONS AS Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo